A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16622464

Br. J. Cancer 2006 May 8 94 9 1281-6

Download in:

View as

Triples

General Info

PMID
16622464